LEADER 01821nam  2200493   450 
001 9910712038303321
005 20190408092350.0
035   $a(CKB)5470000002489720
035   $a(OCoLC)1091895424
035   $a(EXLCZ)995470000002489720
100   $a20190408e19851977  ua             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aReview of inhalants $eeuphoria to dysfunction /$feditors: Charles Wm. Sharp, Mary Lee Brehm
210  1$aRockville, Maryland :$cDepartment of Health and Human Services, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institution on Drug Abuse, Office of Science,$d1985.
215   $a1 online resource (xix, 352 pages) $cillustrations
225 1 $aNIDA research monograph ;$v15
225 1 $aDHHS publication ;$vno. (ADM) 85-553
300   $a"October 1977."
300   $a"Printed 1977. Reprinted 1979, 1985"--Page iv.
320   $aIncludes bibliographical references.
517   $aReview of inhalants 
606   $aSolvents$xToxicology$zUnited States
606   $aSolvents$xPhysiological effect$zUnited States
606   $aInhalant abuse$zUnited States
606   $aInhalant abuse$xTreatment$zUnited States
606   $aDrug abuse$zUnited States
615  0$aSolvents$xToxicology
615  0$aSolvents$xPhysiological effect
615  0$aInhalant abuse
615  0$aInhalant abuse$xTreatment
615  0$aDrug abuse
702   $aSharp$b Charles Wm.$f-2014,
702   $aBrehm$b Mary Lee
712 02$aNational Institute on Drug Abuse.$bOffice of Science,
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910712038303321
996   $aReview of inhalants$93523419
997   $aUNINA